Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Debt-to-Equity : 0.35 (As of Dec. 2021)

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Debt-to-Equity Chart

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
Debt-to-Equity		Get a 7-Day Free Trial					0.53	1.13	0.77	0.77	0.35

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Sep21	Dec21
Debt-to-Equity	Get a 7-Day Free Trial															0.93	0.77	0.33	-	0.35

Competitive Comparison of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity falls into.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Dec. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals  (XPAE:PHARMACARE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Business Description